Yaniv Erlich

Chief Executive Officer Eleven Therapeutics

Thursday 29th January 2026

DELiveri®: discovering cell specific delivery molecules for RNAi using high throughput screens with millions of conjugates

9:00 am

Exploring the role of DELiveri® as a powerful product engine to enable functional screens of millions of delivery molecules in human cells in a one-pot reaction, for improved specificity of RNAi therapies
Evaluating the quantitative output of the screen, providing a score for each molecule, and setting the basis to train AI algorithms
Sharing insights from over 30 screens conducted across multiple primary human cell types, along with in-vivo validation data for novel compounds, to establish a robust predictive framework for translating in vitro results into effective in vivo therapies